Sweeney J, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difﬁcult Asthma Registry. Thorax. 2016;71(4):339-46.
COSA DICE LA SCIENZA?
Gandhi NA et al. Targeting key proximal drivers of type 2 inflammation in disease Nat Rev Drug Discov 2016;15(1):35-50.
Global Initiative for Asthma. Global strategy for Asthma management and prevention, 2018.
Peters MC et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol 2014;133(2):388-394.
Fahy et al. Type 2 inflammation in asthma — present in most, absent in many. Nat Rev Immunol 2015 Jan;15(1):57-65.
Dunican EM, Fahy JV. The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations. Ann Am Thorac Soc 2015;12 Suppl 2:S144–S149.
Muraro A et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2016;137(5):1347-58.
Khan A et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57(1):32-42.